Şunu aradınız:: update of the note (Danca - Almanca)

what are your proposals for the revaluation and update of the lisbon objectives?
was schlagen sie zur neubewertung und aktualisierung der lissabon-ziele vor?

the commission proposed on 14.07.1999 an extension and update of the ’91 directive.
am 14.7.1999 unterbreitete die kommission einen vorschlag zur verlängerung und aktualisierung der richtlinie von 1991.

titel på dokumentet update of note for guidance on non- clinical local tolerance testing of medicinal products
titel update of note for guidance on non-clinical local tolerance testing of medicinal products

forbind til skjult netværkname of the connection not known
mit verborgenem netzwerk verbindenname of the connection not known

note for guidance on pharmaceutical aspects of the product literature for human vaccines
note for guidance on pharmaceutical aspects of the product literature for human vaccines

note for guidance on summary of requirements for active substances in part ii of the dossier
note for guidance on summary of requirements for active substances in part ii of the dossier

problem: cases of fraud which do not fall within the scope of the rules
problem: betrugsfälle, die nicht in den kompetenzbereich fallen

konceptdokument immunotoxicity and the need to update the notes for guidance on repeat dose toxicity and on non - clinical local tolerance testing of medicinal products
cpmp/swp/160/98 immunotoxicity and the need to update the notes for guidance on repeat dose toxicity and on non- clinical local tolerance testing of medicinal products

note for guidance on the format and content of the annual report on the state of development of an orphan medicinal products
note for guidance on the format and content of the annual report on the state of development of an arzneimittel für seltene leiden

concept paper on the development of a cpmp note for guidance on the clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins.
concept paper on the development of a cpmp note for guidance on the clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins.

the required version of the truecrypt boot loader is currently not installed. this may prevent some of the settings from being saved.
die benötigte version des truecrypt-starters ist im moment nicht installiert. dies kann dazu führen, dass einige einstellungen nicht gespeichert werden.

concept paper on the development of a cpmp note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal failure.
emea/mb/055/02/de/endgültig dokumentennummer titel des dokuments guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal failure.

(48) however, the commission is of the preliminary view that the uk authorities have not demonstrated any such circumstances.
(48) however, the commission is of the preliminary view that the uk authorities have not demonstrated any such circumstances.

action in these fields is all the more necessary as the progressive emptying of the countryside has widened the gap between the haves and the have-nots in africa.
der handlungsbedarf in diesen bereichen ist besonders groß, da die fortschreitende landflucht die kluft zwischen den besitzenden und den besitzlosen in afrika vergrößert hat.

concept paper on the revision of the cpmp/ bwp note for guidance (cpmp/ bwp/ 214/ 96) on harmonisation of requirements for influenza vaccines
concept paper on the revision of the cpmp/bwp note for guidance (cpmp/bwp/214/96) on harmonisation of requirements for influenza vaccines

thus far, the european central bank( ecb) has not been consulted on any of the national draft legislative provisions ratifying or implementing the agreement.
die europäische zentralbank( ezb) ist bisher nicht zu entwürfen von nationalen rechtsvorschriften angehört worden, mittels denen das Übereinkommen ratifiziert oder implementiert wird.

however, non-originating articles may be incorporated provided their total value does not exceed 15% of the ex-works price of the set
however, materials of headings 1507, 1508, 1511 and 1513 may be used

(21) in addition, according to the information provided, under the scheme the aid may not exceed 25 % of the value of the vessel.
(21) in addition, according to the information provided, under the scheme the aid may not exceed 25 % of the value of the vessel.

the introduction of e-recording and e-reporting (e-logbooks) need an update of existing networks and an investment in software on board of more than 12.000 vessels.
die einführung elektronischer aufzeichnungen und meldungen (e‑logbücher) macht eine modernisierung der bestehenden netzwerke sowie investitionen in die software an bord von über 12.000 schiffen erforderlich.

adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino- conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms:
adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino-conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms: